I also would be totally opposed to selective access to information on the basis of genetic ancestry. We should never set that precedent. Informed decision-making on the part of the consumer is the only acceptable recourse imo.
Also, from my reading this research the PRS was based on predictions garnered from (self-reported) diagnosed T2DM. The undiagnosed rate of T2DM ranges from 20-50% , so presumably it's made clear that the test might entirely miss genes associated with undiagnosed T2DM?
-
-
The GWAS results from self-reported data replicate the GWAS results from clinically evaluated individuals quite well actually. That is also in the white paper.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.